RISPERIDONE
- Product NDC
- 27241-005
- 11-digit product format
- 272410005
- Labeler code
- 27241
- Product ID
- 27241-005_8ace73a4-053e-4bd8-ad32-b05807e2f6f5
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- RISPERIDONE
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Ajanta Pharma USA Inc.
- Application
- ANDA201003
- Marketing category
- ANDA
- Marketing start
- 2014-03-28
- Substance
- RISPERIDONE
- Active strength
- 3 mg/1
- Pharmacologic classes
- Atypical Antipsychotic [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- RISPERIDONE
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| RISPERIDONE | 3 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | L6UH7ZF8HC |
| Rxcui | 312828, 312829, 312830, 312831, 312832, 314211 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 27241-005-06 | RISPERIDONE | 60 in 1 BOTTLE | TABLET | 60 | | 18 |
| 27241-005-50 | RISPERIDONE | 500 in 1 BOTTLE | TABLET | 500 | | 18 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 27241-005 | RISPERIDONE TABLET [AJANTA PHARMA USA INC.] | 17 | Current NDC, Legacy NDC, 2 package rows | 20250406_095630bd-a77e-434e-94ee-f13da445d8f2.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 27241-005-06 | 27241000506 | 60 TABLET in 1 BOTTLE (27241-005-06) | 60 tablet | 2014-03-28 | 0000-00-00 | No | No | Current |
| 27241-005-50 | 27241000550 | 500 TABLET in 1 BOTTLE (27241-005-50) | 500 tablet | 2014-03-28 | 0000-00-00 | No | No | Current |